Waters Corporation (WAT) Position Cut by Candriam Luxembourg S.C.A.
Candriam Luxembourg S.C.A. lowered its position in shares of Waters Corporation (NYSE:WAT) by 8.1% during the second quarter, according to its most recent filing with the SEC. The fund owned 12,566 shares of the medical instruments supplier’s stock after selling 1,103 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Waters Corporation were worth $2,310,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of the stock. First Manhattan Co. acquired a new stake in Waters Corporation during the second quarter worth approximately $130,000. Daiwa Securities Group Inc. boosted its stake in Waters Corporation by 71.1% in the second quarter. Daiwa Securities Group Inc. now owns 3,850 shares of the medical instruments supplier’s stock worth $708,000 after buying an additional 1,600 shares in the last quarter. Ownership Capital B.V. boosted its stake in Waters Corporation by 6.3% in the second quarter. Ownership Capital B.V. now owns 435,371 shares of the medical instruments supplier’s stock worth $80,039,000 after buying an additional 25,672 shares in the last quarter. Bessemer Group Inc. boosted its stake in Waters Corporation by 40.7% in the second quarter. Bessemer Group Inc. now owns 724,009 shares of the medical instruments supplier’s stock worth $133,101,000 after buying an additional 209,306 shares in the last quarter. Finally, Grandfield & Dodd LLC boosted its stake in Waters Corporation by 34.5% in the second quarter. Grandfield & Dodd LLC now owns 2,400 shares of the medical instruments supplier’s stock worth $441,000 after buying an additional 615 shares in the last quarter. 92.42% of the stock is currently owned by institutional investors and hedge funds.
Shares of Waters Corporation (NYSE WAT) opened at 175.66 on Friday. Waters Corporation has a one year low of $133.35 and a one year high of $187.65. The company has a market capitalization of $14.02 billion, a PE ratio of 26.47 and a beta of 0.84. The stock has a 50 day moving average price of $180.63 and a 200 day moving average price of $167.35.
Waters Corporation (NYSE:WAT) last issued its quarterly earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.05. The firm had revenue of $558.30 million for the quarter, compared to analyst estimates of $553.22 million. Waters Corporation had a net margin of 24.26% and a return on equity of 23.91%. Waters Corporation’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period last year, the company posted $1.58 EPS. On average, equities research analysts predict that Waters Corporation will post $7.38 earnings per share for the current year.
Waters Corporation declared that its Board of Directors has authorized a share buyback plan on Thursday, May 11th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the medical instruments supplier to repurchase up to 7.3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its stock is undervalued.
WARNING: “Waters Corporation (WAT) Position Cut by Candriam Luxembourg S.C.A.” was first published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.dailypolitical.com/2017/08/11/waters-corporation-wat-position-cut-by-candriam-luxembourg-s-c-a.html.
A number of equities research analysts have commented on the company. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $194.00 price target on the stock in a report on Friday, July 28th. BidaskClub cut Waters Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Jefferies Group LLC reissued a “hold” rating and set a $175.00 price target on shares of Waters Corporation in a report on Thursday, July 27th. Morgan Stanley reissued an “underweight” rating and set a $183.00 price target (up from $174.00) on shares of Waters Corporation in a report on Wednesday, July 26th. Finally, Bank of America Corporation reissued a “neutral” rating and set a $192.00 price target (up from $180.00) on shares of Waters Corporation in a report on Friday, July 21st. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $186.00.
In related news, SVP Michael C. Harrington sold 24,000 shares of the firm’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $175.33, for a total value of $4,207,920.00. Following the transaction, the senior vice president now directly owns 28,073 shares of the company’s stock, valued at approximately $4,922,039.09. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Rohit Khanna sold 10,000 shares of the firm’s stock in a transaction dated Thursday, May 18th. The shares were sold at an average price of $176.46, for a total transaction of $1,764,600.00. Following the completion of the transaction, the senior vice president now directly owns 14,077 shares in the company, valued at $2,484,027.42. The disclosure for this sale can be found here. Insiders sold a total of 98,580 shares of company stock worth $17,730,275 over the last ninety days. 5.07% of the stock is currently owned by corporate insiders.
Waters Corporation Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT).
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.